Initiator Pharma A/S

SSE:INIT.ST

8.08 (SEK) • At close February 20, 2024
Bedrijfsnaam Initiator Pharma A/S
Symbool INIT.ST
Munteenheid SEK
Prijs 8.08
Beurswaarde 427,579,056
Dividendpercentage 0%
52-weken bereik 5 - 12.2
Industrie Biotechnology
Sector Healthcare
CEO Dr. Claus Elsborg Olesen
Website https://www.initiatorpharma.com

An error occurred while fetching data.

Over Initiator Pharma A/S

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an

Vergelijkbare Aandelen

OssDsign AB (publ) logo

OssDsign AB (publ)

OSSD.ST

8.8 SEK

Alligator Bioscience AB (publ) logo

Alligator Bioscience AB (publ)

ATORX.ST

1.178 SEK

Kancera AB (publ) logo

Kancera AB (publ)

KAN.ST

4.095 SEK

Guard Therapeutics International AB (publ) logo

Guard Therapeutics International AB (publ)

GUARD.ST

19.8 SEK

I-Tech AB logo

I-Tech AB

ITECH.ST

39.7 SEK

Ortivus AB (publ) logo

Ortivus AB (publ)

ORTI-B.ST

3.44 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)